newsfilter
← Latest News
PR Newswire·

BiondVax announces Second Quarter 2022 Financial Results and Provides Business Update

JERUSALEM, Aug. 25, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today pu